CytoDyn (CYDY) Shares Outstanding (Diluted) (2020 - 2026)

CytoDyn (CYDY) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 CytoDyn 258.01 Mn 258.01 Mn - 1.28 Bn

Historic Data

Download Data
DateValue
Feb 28, 2026 1.28 Bn
Nov 30, 2025 1.26 Bn
Aug 31, 2025 1.25 Bn
May 31, 2025 1.24 Bn
Feb 28, 2025 1.23 Bn
Nov 30, 2024 1.22 Bn
Aug 31, 2024 1.20 Bn
May 31, 2024 969.51 Mn
Feb 29, 2024 982.21 Mn
Nov 30, 2023 958.99 Mn
Aug 31, 2023 923.59 Mn
May 31, 2023 836.53 Mn
Feb 28, 2023 832.22 Mn
Nov 30, 2022 813.37 Mn
Aug 31, 2022 787.86 Mn
May 31, 2022 676.90 Mn
Feb 28, 2022 695,614.00
Nov 30, 2021 662.60 Mn
Aug 31, 2021 632.60 Mn
May 31, 2021 587.59 Mn